Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.

Ravera M, Gabano E, Sardi M, Ermondi G, Caron G, McGlinchey MJ, Müller-Bunz H, Monti E, Gariboldi MB, Osella D.

J Inorg Biochem. 2011 Mar;105(3):400-9. doi: 10.1016/j.jinorgbio.2010.12.002. Epub 2010 Dec 14.

PMID:
21421126
2.

Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.

Marqués-Gallego P, Contaldi S, den Dulk H, Monari M, Brouwer J, Jaehde U, Kalayda GV, Reedijk J.

J Inorg Biochem. 2009 Dec;103(12):1602-8. doi: 10.1016/j.jinorgbio.2009.08.009. Epub 2009 Sep 2.

PMID:
19783310
3.

Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.

Alvarez-Valdés A, Pérez JM, López-Solera I, Lannegrand R, Continente JM, Amo-Ochoa P, Camazón MJ, Solans X, Font-Bardía M, Navarro-Ranninger C.

J Med Chem. 2002 Apr 25;45(9):1835-44.

PMID:
11960495
4.

Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.

Roy S, Westmaas JA, Buda F, Reedijk J.

J Inorg Biochem. 2009 Sep;103(9):1278-87. doi: 10.1016/j.jinorgbio.2009.07.004. Epub 2009 Aug 4.

PMID:
19656572
6.

Synthesis, characterization and cytotoxicity of dihalogeno-platinum(II) complexes with L-histidine ligand.

Ye QS, Xie MJ, Liu WP, Chen XZ, Yu Y, Chang QW, Hou SQ.

Chem Pharm Bull (Tokyo). 2009 Apr;57(4):424-7.

7.

Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.

Matesanz AI, Joie C, Souza P.

Dalton Trans. 2010 Aug 14;39(30):7059-65. doi: 10.1039/c003007d. Epub 2010 Jun 23.

PMID:
20571622
9.

Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.

Starha P, Trávnícek Z, Popa I.

J Inorg Biochem. 2010 Jun;104(6):639-47. doi: 10.1016/j.jinorgbio.2010.02.005. Epub 2010 Mar 3.

PMID:
20304500
10.

Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.

Margiotta N, Natile G, Capitelli F, Fanizzi FP, Boccarelli A, De Rinaldis P, Giordano D, Coluccia M.

J Inorg Biochem. 2006 Nov;100(11):1849-57. Epub 2006 Aug 3.

PMID:
16959321
11.
12.
13.

Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes.

Kwon YE, Whang KJ, Park YJ, Kim KH.

Bioorg Med Chem. 2003 Apr 17;11(8):1669-76.

PMID:
12659753
14.
15.

Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.

Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C.

J Med Chem. 2007 Sep 20;50(19):4775-84. Epub 2007 Aug 22.

PMID:
17713897
16.

Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.

Cerè V, Grossi L, Munari D, Pollicino S, Martelli L, Martelli M.

Anticancer Res. 2006 May-Jun;26(3A):1815-9.

17.

Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.

Dolfen D, Schottler K, Valiahdi SM, Jakupec MA, Keppler BK, Tiekink ER, Mohr F.

J Inorg Biochem. 2008 Dec;102(12):2067-71. doi: 10.1016/j.jinorgbio.2008.07.002. Epub 2008 Jul 11.

PMID:
18707761
18.

Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.

Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.

Biol Chem. 1999 Nov;380(11):1287-94.

PMID:
10614821
19.

Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.

Saczewski F, Dziemidowicz-Borys E, Bednarski PJ, Gdaniec M.

Arch Pharm (Weinheim). 2007 Jul;340(7):333-8.

PMID:
17611942
20.

Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.

Kim DK, Kim G, Gam J, Cho YB, Kim HT, Tai JH, Kim KH, Hong WS, Park JG.

J Med Chem. 1994 May 13;37(10):1471-85.

PMID:
8182706
Items per page

Supplemental Content

Write to the Help Desk